Proteins that specifically recognize cisplatin‐damaged DNA: a clue to anticancer activity of cisplatin
- 1 July 1998
- journal article
- review article
- Published by Wiley in The FASEB Journal
- Vol. 12 (10), 791-799
- https://doi.org/10.1096/fasebj.12.10.791
Abstract
Cisplatin, but not its trans geometric isomer, is a potent anticancer drug whose biological activity is a consequence of the formation of covalent adducts between the platinum compound and certain ...Keywords
Funding Information
- National Institutes of Health (GM50276)
This publication has 54 references indexed in Scilit:
- Cisplatin adducts in DNA: distortion and recognitionJBIC Journal of Biological Inorganic Chemistry, 1996
- Identification of a damaged-DNA binding domain of the XPA proteinMutation Research/DNA Repair, 1996
- The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeastMutation Research/DNA Repair, 1996
- Binding of Ixr1, a Yeast HMG-Domain Protein, to Cisplatin−DNA Adducts in Vitro and in VivoBiochemistry, 1996
- The other function of DNA photolyase: stimulation of excision repair of chemical damage to DNABiochemistry, 1995
- Interaction between Cisplatin-modified DNA and the HMG Boxes of HMG 1: DNase I Footprinting and Circular DichroismJournal of Molecular Biology, 1995
- Induction of UV-Damage Recognition Protein by Cisplatin TreatmentBiochemistry, 1995
- The XPA protein is a zinc metalloprotein with an ability to recognize various kinds of DNA damageMutation Research/DNA Repair, 1994
- T4 Endonuclease VII Cleaves DNA Containing a Cisplatin AdductJournal of Molecular Biology, 1993
- Characterization of high mobility group protein binding to cisplatin-damaged DNABiochemical and Biophysical Research Communications, 1992